GZPH.F Stock Overview
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$2.88 |
| 52 Week High | HK$3.03 |
| 52 Week Low | HK$2.16 |
| Beta | 0.69 |
| 1 Month Change | 0% |
| 3 Month Change | -1.03% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | -39.50% |
| Change since IPO | 1,340.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| GZPH.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -3.4% | -1.7% |
| 1Y | n/a | -5.6% | 22.4% |
Return vs Industry: Insufficient data to determine how GZPH.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how GZPH.F performed against the US Market.
Price Volatility
| GZPH.F volatility | |
|---|---|
| GZPH.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GZPH.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine GZPH.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 24,249 | Hong Li | www.gybys.com.cn |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People’s Republic of China and internationally. The company operates through four segments: Great Southern Medicine, Great Commerce, Great Health, and Great Medical Care. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, and medical devices; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, Guiling jellies, etc. In addition, the company invests in health industry, such as medical services, health management, health care, elderly care, etc.; and provides business and advertising agency services.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Fundamentals Summary
| GZPH.F fundamental statistics | |
|---|---|
| Market cap | US$7.85b |
| Earnings (TTM) | US$576.14m |
| Revenue (TTM) | US$10.18b |
9.0x
P/E Ratio0.5x
P/S RatioIs GZPH.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GZPH.F income statement (TTM) | |
|---|---|
| Revenue | CN¥71.88b |
| Cost of Revenue | CN¥58.44b |
| Gross Profit | CN¥13.44b |
| Other Expenses | CN¥9.37b |
| Earnings | CN¥4.07b |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.50 |
| Gross Margin | 18.70% |
| Net Profit Margin | 5.66% |
| Debt/Equity Ratio | 34.9% |
How did GZPH.F perform over the long term?
See historical performance and comparison